Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early puberty

Archives of Disease in Childhood

Volumn 79, Issue 4, 1998, Pages 323-327

  Paterson, W F ^a   McNeill, E ^a   Reid, S ^b   Hollman, A S ^b   Donaldson, M D C ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b Royal Hospital for Sick Children

Author keywords

Central precocious puberty; Gonadotrophin releasing hormone analogue treatment; Height velocity

Indexed keywords

GOSERELIN;

AFFECTIVE NEUROSIS; ARTICLE; BODY HEIGHT; CHILD GROWTH; CLINICAL ARTICLE; FEMALE; GROWTH RATE; HUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0031719873     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.4.323     Document Type: Article

References (16)

1. Crowley WF Jr, Comite F, Vale W, et al. Therapeutic use of pituitary desensitisation with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981;52:370-2.
2. Wheeler MD, Styne DM. Drug treatment in precocious puberty. Drugs 1991;41:717-28.
3. Breyer P, Haider A, Pescovitz OH. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty. Clin Obstet Gynecol 1993;36:764-72.
4. Merke DP, Cutler GB. Evaluation and management of precocious puberty. Arch Dis Child 1996;75:269-71.
5. Bassi F, Serio M. Trattamento con agonista LH-RH (Zoladex depot) in soggetti affetti da puberta precoce. Drugs Exp Clin Res 1990;XVI(suppl):33-7.
6. Rangasami JJ, Grant DB. Familial precocious puberty in girls. J R Soc Med 1992;85:497-8.
7. Thomas BC, Stanhope R, Leiper AD. Gonadotrophin releasing hormone analogue and growth hormone therapy in precocious and premature puberty following cranial irradiation for acute lymphoblastic leukaemia. Horm Res 1993;39:25-9.
8. Griffin IJ, Cole TJ, Duncan KA, Hollman AS, Donaldson MDC. Pelvic ultrasound measurements in normal girls. Acta Paediatr 1995;84:536-43.
9. Kauli R, Pertzelan A, Ben-Zeer Z, et al. Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate - further experience. Clin Endocrinol 1984;20:377-87.
10. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H. Assessment of skeletal maturity and prediction of adult height (TW2 method). 2nd ed. London: Academic Press, 1983.
11. Tanner JM. Growth at adolescence. 2nd ed. Oxford: Blackwell Scientific Publications, 1962.
12. Griffin IJ, Cole TJ, Duncan KA, Hollman AS, Donaldson MDC. Pelvic ultrasound findings in different forms of sexual precocity. Acta Paediatr 1995;84:544-9.
13. Stanhope R, Adams J, Jacobs HS, Brook CJD. Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Arch Dis Child 1985;60:116-19.
14. Donaldson MDC, Stanhope R, Lee TJ, Price DA, Brook CGD, Savage DCL. Clin Endocrinol 1984;21:499.
15. Brauner R, Adan L, Malandry F, Zantleifer D. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 1994;79:415-20.
16. Oostdijk W, Rikken B, Schreuder S, et al. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996;75: 292-7.